KMB

Kimberly-Clark
D

KMB

Arincen66/100B

Kimberly-Clark revenue 1985–2026

Kimberly-Clark's revenue in Q3 FY2026, the three months to 30 September 2026, was 4.13B USD, up 0.0% on the same quarter a year before. Kimberly-Clark's revenue over the last twelve months was 16.57B USD, down 8.3% on the twelve months before. In fiscal year 2025 it was 17.22B USD, down 14.2% on the year before.

Last updated 6 Nov 2026 · Next report 26 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202616.57B-8.29%6.04B3.30B
FY202531 Dec 202517.22B-14.17%6.13B2.02B
FY202431 Dec 202420.06B-1.83%7.18B2.55B
FY202331 Dec 202320.43B+1.27%7.03B1.76B
FY202231 Dec 202220.18B+3.78%6.22B1.93B
FY202131 Dec 202119.44B+1.57%5.99B1.81B
FY202031 Dec 202019.14B+3.74%6.82B2.35B
FY201931 Dec 201918.45B-0.19%6.04B2.16B
FY201831 Dec 201818.49B+1.24%5.60B1.41B
FY201731 Dec 201718.26B+0.31%6.59B2.28B
FY201631 Dec 201618.20B-2.09%6.69B2.17B
FY201531 Dec 201518.59B-5.74%6.62B1.01B
FY201431 Dec 201419.72B-6.75%6.68B1.53B
FY201331 Dec 201321.15B+0.42%7.24B2.14B
FY201231 Dec 201221.06B+1.04%6.75B1.75B
FY201131 Dec 201120.85B+5.57%6.15B1.59B
FY201031 Dec 201019.75B+3.30%6.55B1.84B
FY200931 Dec 200919.12B-1.55%6.42B1.88B
FY200831 Dec 200819.42B+6.29%5.86B1.69B
FY200731 Dec 200718.27B+9.07%5.70B1.82B
FY200631 Dec 200616.75B+5.31%5.42B1.50B
FY200531 Dec 200515.90B+5.43%5.08B1.57B
FY200431 Dec 200415.08B+5.12%5.07B1.80B
FY200331 Dec 200314.35B+5.76%4.90B1.69B
FY200231 Dec 200213.57B-6.60%4.69B1.67B
FY200131 Dec 200114.52B+3.88%5.91B1.61B
FY200031 Dec 200013.98B+7.50%6.35B1.80B
FY199931 Dec 199913.01B+5.77%5.91B1.67B
FY199831 Dec 199812.30B-1.98%5.21B1.17B
FY199731 Dec 199712.55B-4.58%5.06B901.50M
FY199631 Dec 199613.15B-4.64%5.47B1.40B
FY199531 Dec 199513.79B+87.24%5.54B33.20M
FY199431 Dec 19947.36B+5.61%2.77B535.10M
FY199331 Dec 19936.97B-1.67%2.69B510.90M
FY199231 Dec 19927.09B+4.64%2.85B135.00M
FY199131 Dec 19916.78B+5.77%2.71B508.30M
FY199031 Dec 19906.41B+11.75%2.43B432.10M
FY198931 Dec 19895.73B+6.31%2.29B423.80M
FY198831 Dec 19885.39B+10.42%2.18B378.60M
FY198731 Dec 19874.88B+13.52%2.00B325.20M
FY198631 Dec 19864.30B+5.65%1.59B269.40M
FY198531 Dec 19854.07B—1.70B267.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Kimberly-Clark revenue growth by segment

Q3 FY2026 against Q3 FY2025

Diapers1.60B
-5.1%
Consumer tissue products1.07B
+2.9%
Adult care products512.00M
+4.5%
Away from Home Professional Products482.00M
+1.7%
Feminine care products433.00M
+0.5%

Kimberly-Clark revenue by segment over time

Diapers Consumer tissue products Adult care products Away from Home Professional Products Feminine care products Personal Care Consumer Tissue K-C Professional
Fiscal yearDiapersConsumer tissue productsAdult care productsAway from Home Professional ProductsFeminine care productsPersonal CareConsumer TissueK-C Professional
FY20256.77B 4.06B 1.95B 1.84B 1.71B — — —
FY2024— — — — — — 6.16B -2.1%—
FY2023— — — — — 10.69B +0.6%6.29B +0.8%3.40B +4.5%
FY2022— — — — — 10.62B +3.5%6.24B +3.5%3.26B +6.0%
FY2021— — — — — 10.27B +9.9%6.03B -10.2%3.07B +1.8%
FY2020— — — — — 9.34B +2.5%6.72B +12.1%3.02B -8.3%
FY2019— — — — — 9.11B +0.8%5.99B -0.4%3.29B -2.7%
FY2018— — — — — 9.04B -0.5%6.02B +1.4%3.38B +5.4%
FY2017— — — — — 9.08B +0.4%5.93B -0.6%3.21B +1.8%
FY2016— — — — — 9.05B -1.7%5.97B -2.5%3.15B -2.1%

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Kimberly-Clark's revenue

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.